Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Science (London, England : 1979)|September 1, 1988
Zinc status in inflammatory bowel diseaseC C Ainley, J Cason, L K Carlsson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1993
Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic controlS K Jain, D K Nagi, B M Slavin, et al.
Journal of Clinical Pathology|August 1, 1994
Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patientsJ C Mazurkiewicz, G F Watts, F G Warburton, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 1995
Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosisG F Watts, J C Mazurkiewicz, K Tonge, et al.
Clinical Chemistry|December 1, 1994
Metabolic determinants of the course of coronary artery disease in menG F Watts, S Mandalia, B M Slavin, et al.
Archives of Disease in Childhood|October 1, 1978
Hypomagnesaemic hypocalcaemia with hypokalaemia caused by treatment with high dose gentamicinC J Kelnar, W S Taor, D J Reynolds, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1989
Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuriaG F Watts, R Naumova, B M Slavin, et al.
Journal of Clinical Pathology|March 1, 1985
Familial abnormalities of thyroxine binding proteins: some problems of recognition and interpretationJ E Neild, P G Byfield, M R Lalloz, et al.
Pageof 3